We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Medical Treatment Better Than Brain Stenting in Preventing Stroke

By HospiMedica International staff writers
Posted on 29 Sep 2011
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received percutaneous transluminal angioplasty and stenting (PTAS) in addition to the medical treatment, according to a new study.

Researchers at University Hospitals (UH) Case Medical Center (Cleveland, OH, USA), the Medical University of South Carolina (Charleston, USA), and other institutions randomly assigned patients who suffered a recent transient ischemic attack (TIA) or stroke attributed to stenosis in a major intracranial artery to aggressive medical management alone, or to aggressive medical management plus PTAS. More...
The primary end point was stroke or death within 30 days after enrollment, or a revascularization procedure for the qualifying lesion during the follow-up period, or stroke in the territory of the qualifying artery beyond 30 days.

Enrollment in the study was stopped after 451 patients underwent randomization, because the 30-day rate of stroke or death was 14.7% in the PTAS group, compared to 5.8% in the medical-management group. Beyond 30 days, stroke in the same territory occurred in 13 patients in each group. Currently, the mean duration of the ongoing follow-up is one year. The probability of the occurrence of a primary end-point event over time differed significantly between the two treatment groups, with one-year rates of the primary end point of 20% in the PTAS group and 12.2% in the medical-management group. The results were published early online on September 15, 2011, in the New England Journal of Medicine (NEJM).

“For now, we are thrilled that the effect of a very aggressive patient care plan to address all of their risk factors and make lifestyle changes to healthier living have demonstrated a significant impact in preventing stroke, and this impact is significant in as early as one month,” said lead author professor of neurology Cathy Sila, MD, director of the stroke and cerebrovascular center in the UH Neurological Institute. “I think this is a major achievement. The stroke or transient ischemic attack is the 'warning shot across the bow' and we need to get into battle mode immediately.”

A stroke, previously known medically as a cerebrovascular accident (CVA), is the rapidly developing loss of brain function due to disturbance in the blood supply to the brain. This can be due to ischemia caused by thrombosis or arterial embolism, or as a result of intracranial hemorrhage. Consequently, the affected area of the brain is unable to function, which might result in an inability to move one or more limbs on one side of the body, inability to understand or formulate speech, or an inability to see one side of the visual field.

Related Links:

University Hospitals (UH) Case Medical Center
Medical University of South Carolina






Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.